Canaccord Genuity adjusted its outlook on ServiceNow (NYSE:NOW) shares, raising the price target to $1,275 from the previous ...

Canaccord Genuity analyst John Newman maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) today and set a price target of ...

Canaccord Genuity analyst Brian McNamara maintained a Hold rating on Rollins (ROL – Research Report) today and set a price target of $48.00.

Middleby (NASDAQ:MIDD – Get Free Report) had its price objective increased by equities research analysts at Canaccord Genuity ...

Stride (NYSE:LRN – Get Free Report) had its price target increased by investment analysts at Canaccord Genuity Group from ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.82% of ...

Work to create a tram museum to showcase Blackpool's heritage fleet is being stepped up, with volunteers hoping to submit a bid for National Lottery funding to boost the scheme. The team behind ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

Canaccord downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $74, after Stryker (SYK) entered into a definitive agreement to acquire Inari in cash for $80 per ...

History therefore suggests that the current conditions represent a buying opportunity in silver.” Canaccord Genuity Australia equity research analyst Tom Prendiville says while the gold-to-silver ...

Thank you for signing up! Did you know with a Digital Subscription to Blackpool Gazette, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ...